Preventice Receives CE Mark for BodyGuardian Remote Monitoring ECG System

European clinical trial interest remains strong; company poised for global distribution


October 11, 2013
ECG holter remote monitoring patient systems preventice BodyGuardian mayoclinic

October 11, 2013 — Preventice Inc. has received CE mark certification for its BodyGuardian remote monitoring system.

Developed in collaboration with Mayo Clinic, the BodyGuardian uses algorithms to support remote monitoring for individuals with cardiac arrhythmias. The BodyGuardian allows physicians to monitor biometrics outside the clinical setting. A small body sensor attached to the patient's chest collects important data, including the patient's electrocardiogram (ECG), heart rate, respiration rate and activity level. Patient data can then be transmitted to physicians via mobile phone technology.

Preventice received U.S. Food and Drug Administration (FDA) clearance in August 2012 and recently received ISO 13485: 2003 certification.

Jon Otterstatter, co-founder, president and CEO, Preventice, noted that use of remote monitoring technology in healthcare is already on the rise, and that Preventice was named as a leading resource for ECG remote monitoring in the most recent "Hype Cycle for Telemedicine, 2013," from Gartner Research. Gartner analysts noted the potential for remote monitoring technology to improve the patient experience, address the looming shortage in healthcare workers, reduce hospital readmissions and positively impact healthcare trends.

BodyGuardian is supported by the Preventice Care Platform, a cloud-based mHealth Platform that collects real-time data from devices and delivers information to medical monitoring professionals.

For more information:,